chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Problems with their colon; Flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu symptoms) and COLON INJURY (Problems with their colon) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, the patient experienced INFLUENZA (Flu symptoms). On an unknown date, the patient experienced COLON INJURY (Problems with their colon). The patient was treated with PARACETAMOL, PHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE (THERAFLU [PARACETAMOL;PHENIRAMINE MALEATE;PHENYLEPHRINE HYDROCHLORIDE]) ongoing since an unknown date for Flu, at a dose of 1 dosage form. At the time of the report, INFLUENZA (Flu symptoms) and COLON INJURY (Problems with their colon) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Significant follow up appended-Added reporter details, Patient demographics, Product details, Treatment medication, Event start date.
Info has been received from a licensed practical nurse concerning a 27 year-old male volunteer firefighter with no known allergies and no known medical conditions who on 12/02/2002 at 19:00 was vaccinated intramuscularly in the deltoid with a 1st dose of pneumococcal vaccine 23 polyvalent (lot number 643251/0445M). The dose was "given with a 25 guage, 1" needle". There was no concomitant medication. There was no illness at the time of vaccination and no symptoms following prior vaccinations with the pt or his siblings. It was noted that 2 hours after the vaccine was given, he spent 20 hours at a fire scene and was engaged at times in "heavy physical labor". On 12/03/2002 at 21:00 the pt developed pain and "induration from elbow to shoulder", but did not require medical care as a result of this. It was also noted that the nurse suspected the "activity played a major role in their reactions". The pt recovered on 12/06/2002 after 48 hours. The nurse also reported on 9 other pts that were vaccinated with a 1st dose of pneumococcal vaccine 23 polyvalent (lot #643251/0445M) and developed induration (WAES #0212USA01192, 0212USA01193, 0212USA00729, 0212USA00825, 0304USA02075, 0304USA02076, 0304USA02078, 0304USA02079 and 0304USA02081. No further info is expected.
6hrs after the vaccine I started having chills, body aches, light headed, & headache. Also at the same time I started spotting which I found out it was the symptoms of a miscarriage. On 04/11/2021 I continued with the same symptoms then later on that night i started feeling dizzy the bleeding continued. Around 2am on 4/12/2021 I was bleeding a lot & at 7am I went to the ER and they confirmed I had a miscarriage. I was 11 weeks pregnant. My estimated delivery date was 10/28/2021. On my previous appointments they said everything was going good with my pregnancy the only complication was hyperthyroidism which I had been taking medication for.
Pt developed hive like reaction the day of vaccines, was advised to take Benadryl and it had cleared up but returned the next day. Pt also had a temp of 102 that was reduced with Tylenol. They followed up in the office with our provider on 11/12/2020
About eight days after the first dose of my vaccine my arm became irritated. I was also experiencing mild flu like symptoms and I was tested for Covid-19 and tested negative. I was breastfeeding at the time. My arm was red raised and itchy around the site of vaccine. It was about golf ball size. I took Ibuprofen which helped. I first noticed it because it was very itchy. It was much better the next day in the morning.
I had a general feeling of a cold, sneezing and little cough and achy. I started to run allow grade fever and then I was at the hospital with my husband while he was having a procedure done, I passed out. I was then taken down to the locale ER and they discovered I was positive for COVID-19. The medication did work, and I fully recovered within two weeks and I isolated during this time.
Jynneos vaccine was administered intradermally; The nurse was used a vial of the Jynneos that was punctured and left in the refrigerator for more than eight hours (for 22 hours to be exact) and was administered to a patient; The nurse was used a vial of the Jynneos that was punctured and left in the refrigerator for more than eight hours (for 22 hours to be exact) and was administered to a patient; Case reference number US-BN-2022-004182 is a spontaneous case report initially received on 12-Oct-2022 from a pharmacist via Communications (reference number: USBAV22-1688) and concerns a patient of unknown demographics.  The patient's medical history and concomitant medication details were not provided.  On an unspecified date, the nurse used a vial of the Jynneos (Smallpox and Monkeypox Vaccine, Live, Nonreplicating; batch number was not provided) that was punctured and left in the refrigerator for more than eight hours (for 22 hours to be exact) and was administered to the patient, at an unknown dose and site of administration, intradermally for unknown indication. (Explicitly coded as 'product storage error', 'product administration error' and 'intradermal injection).  At the time of this report, it was unknown if the patient experienced any adverse events.  Additional information received on 12-Oct-2022 included local case ID.; Reporter's Comments: A patient of unknown demographics was vaccinated with the Jynneos vaccine on an unspecified date. Reportedly, the nurse used a vial of the Jynneos that was punctured and left in the refrigerator for more than eight hours, 22 hours to be exact, and was later administered to the patient at an unknown dose and site of administration, intradermally for unknown indication, which is considered as product storage error, product administration error and intradermal injection. All three events are listed per the Company conventions. The patient's medical history and concomitant medication details were not provided. It was unknown if the patient experienced any adverse events following vaccination. Product storage error, product administration error and intradermal injection are assessed as not related to the suspect vaccine, but related to a human factor. The case is non-serious.; Sender's Comments: A patient of unknown demographics was vaccinated with the Jynneos vaccine on an unspecified date. Reportedly, the nurse used a vial of the Jynneos that was punctured and left in the refrigerator for more than eight hours, 22 hours to be exact, and was later administered to the patient at an unknown dose and site of administration, intradermally for unknown indication, which is considered as product storage error, product administration error and intradermal injection. All three events are listed per the Company conventions. The patient's medical history and concomitant medication details were not provided. It was unknown if the patient experienced any adverse events following vaccination. Product storage error, product administration error and intradermal injection are assessed as not related to the suspect vaccine, but related to a human factor. The case is non-serious.
This spontaneous report as received from a medical assistant or nurse via a company representative refers to a 34 year old female patient. On 12-SEP-2012 the patient was vaccinated with PNEUMOVAX 23 subcutaneous (dose and lot# were not reported). Concomitant therapies included B-12 injection that was injected on the patient's right arm. On 12-SEP-2012, within 24 hours after the patient was vaccinated, she experienced significant pain, redness and swelling that included a rash (extended through most of her left arm) at the injection site of PNEUMOVAX 23. On unknown date the patient also experienced fever of 101 F that lasted for three days. Patient took TYLENOL and ALEVE on her own on unknown date. There were not laboratory studies performed. Patient did not seek medical attention; however a call was made to physician to inquired about the adverse events. The outcome of the events was unknown. Additional information is not expected due to the physician did not want to be contacted.
Patient sat on the bench after receiving the Pfizer vaccine and passed out on the floor without any injuries to the body. He woke up ten seconds later and proceeded to vomit. He refused any further help and denied emergency services. We asked him to sit longer so we could continue to monitor. After 20 minutes, the patient was walking out on his own with his family.
This spontaneous report as received from a registered nurse refers to patients of unknown age and gender. 14 doses of VARIVAX (Merck) (Lot number, dose and frequency was unknown) were improperly stored and administered to patients. After 25-NOV-2014. Temperature range was 10/8 Fahrenheit degrees Celsius (F). The time frame was 48 minutes. No adverse events were reported. The outcome of the event was not reported. Follow up information has been received from the same nurse on 17-DEC-2014. The nurse reported that "several" doses (unspecified of how many doses and unspecified if it was the VARIVAX (Merck) or ZOSTAVAX or both) were administered after the temperature excursion. No adverse effect reported. No further information was provided. This is one of several reports received from the same reporter. Additional information is not expected because the nurse requested not to receive any additional follow-up.
Adult hepatitis A administered instead of pediatric hepatitis A because patient 18 yrs old.
Information has been received from a health professional concerning a 44 year old female employee with environmental allergies who in approximately 1998, approximately 8 years ago, was vaccinated with two doses of Varivax. On 04-APR-2006 the patient failed an antibody test. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Approximately 15 hours after receiving the shot I presented with a fever and chills. I took OTC Tylenol at the recommended 6 tablets in 24 hours. My symptoms subsided in about a day   During my first round, I had a swollen lymph node by my collar bone that came up roughly a week after the shot. It is still slightly swollen
Shortly after the vaccination I noticed my arm began to get very pain and have a burning sensation.  The next morning it was really hot and painful still having that same burning sensation so  I contacted a physician at the clinic because  the injection site was swollen, hot and red.  On 12/30 it was about the same but was advised it was infected and given a 10 day antibiotic, which it started getting better but after about day 5 the infection back so my Dr. changed my antibiotic and after the 10day dose it cleared up.  My arm is still a little dark where the infection was.
intense headache; This spontaneous report was received from a registered nurse and refers to an 11-year-old female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 19-AUG-2020, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) intramuscularly (exact dose, site of injection, frequency, lot# and expiration date were not reported for prophylaxis (indication reported as "vaccination"), meningococcal vaccine (unspecified) and diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid (exact dose, site and route of administration, lot# and expiration date were not reported) for prophylaxis. On 21-AUG-2020, the patient woke up with an intense headache. She did not seek medical attention, she just reported the event to her healthcare provider.  The outcome of the event was unknown. The relatedness between the event and suspect vaccines was not provided.
Initial information received on 19-Mar-2019 regarding an unsolicited valid non-serious case received from a Nurse. This case involves a 26 years old female patient who received a 0.5 ml TYPHIM VI, standard single dose syringe, lot N1K121M, expiration date: 30-Oct-2019 via subcutaneous route in unknown administration site on an unknown date. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was an actual medication error due to inappropriate route of vaccination. Patient received a dose of TYPHIM VI subcutaneous instead of Intramuscular. It was unknown whether patient experienced any adverse event following vaccination. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Fully vaccinated patient admitted to hospital for COVID.  Patient with positive COVID exposure reported at work on 07/25/21.  Fully vaccinated with Jansenn vaccine in May.  Patient admitted through ED for shortness of breath and hypoxia at 88%.  Admitted for shortness of breath, dizziness, headache, cough, pleuritc chest pain.  Recieved Remdesivir, Decadron, Actemra, IV lasix, ATB's.  Sent home on portable O2 and 3L/nasal cannula.
Patient states, she received 2nd dose of pfizer COVID19 vaccination on 4/22/21  Pfizer ER8736  Since then with fatigue and generalized  joint pains. Significant left arm pain (injection site), with left axilla swelling that has improved.  Pt has not yet notifed VAERS.
Shortness of breath Arm pain Lump under left arm pit Pain goes across chest and down arm No fever Achy all over Left arm down to fingers and up the arm and across the chest to swollen arm under arm pit is in pain
Dizziness, Headache, Myalgia & NauseaVomiting  Narrative:
This spontaneous report was published in an online article, referring to multiple patients of unknown age and gender. The Centers for Disease Control and Prevention (CDC) currently recommended that children got two doses of M-M-R vaccine - for measles, mumps and rubella - with the first dose at 12 to 15 months of age and the second at 4 to 6 years. The mumps component of the M-M-R vaccine was about 88 percent effective when a person got two doses; one dose was about 78 percent effective. The country's mumps vaccination program began in 1967.  Federal health officials were evaluating the benefit of an additional dose of mumps vaccine because of the increasing number of mumps outbreaks since 2006. More than 5,000 cases of the contagious viral illness were reported last year, the most in a decade. Among the numerous outbreaks in recent years, 19 occurred last year at college campuses. A federal health official had been battling an outbreak that began in one community last summer and had since infected 2, 815 people, the largest ever recorded in a state. Unlike outbreaks of measles and whooping cough, which had taken place in populations with significant numbers of unvaccinaled people, the mumps outbreaks had been occurring in communities with high rates of immunization and residents who often had received both recommended doses of the vaccine (dose, dose number, route, lot# and expiration were unspecified). Although the disease had not been serious, the disruption and expense it had caused for local and state health officials has been significant. Two universities just reported the cases on an unknown date in February 2017(reported as the last three weeks).  The health officials said a major factor contributing to outbreaks was a crowded environment College campuses, where large numbers of students circulate in classes, dormitories and on sports teams, were prime for spreading the virus. In a state, the ongoing outbreak started in a community. The people in crowded housing conditions, often with 15 to 20 people in a single home. From there the outbreak quickly spread across the state to include broader communmes and all age groups.  Even with the large number of cases, the incidence of severe complications had been dramatically reduced, especially among vaccinated children and adults. The outcome of mumps was unknown. The relationship between the event and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (manufacturer unknown) was not reported. Additional information has been requested.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's medical history, concurrent conditions or concomitant medications. On or about 19-SEP-2012, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration unknown) as recommended for routine adult health maintenance and the prevention of shingles. It was reported that the vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 25-MAR-2013, the patient was treated by a nurse practitioner at a heart and vascular center for the onset of a severe vesicular eruption accompanied by weakened immune symptoms, which was diagnosed as herpes zoster. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Nausea, diarrhea, headache, fever as high as 102, tachycardia, chills, muscle and joint pain
EMPLOYEE STATED SHE FELT CLAMMY 10 MINS AFTER INJECTION. DONOR THEN STATED SHE FELT NAUSEOUS AND VOMITED.
Diarrhea, chest pain, fast heartbeat, shortness of breath, severe headache
I thought it was a sinus thing but I called an ENT and was diagnosed with 70% of nerve damage in the right ear.
4/14/18: patient reports dizziness/lightheadedness...severe swelling and warmth at the injection site (wheal and flare)...reports to ER on 4/14, is prescribed Cephalexin 500mg QID x 7d, begins this treatment 4/14. On 4/16 the reaction is improved but patient follows up with primary practitioner, who discontinues Cephalexin and replaces with Levofloxacin 500mg QD x 5d, plus Prednisone 3-day taper. Patient is significantly improved with no further CNS symptoms on 4/17; dermatologic reaction is greatly improved.
; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (The Moderna vaccines have undergone several temperature excursions and may have been administered to patient), PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified) and NO ADVERSE EVENT (No adverse event) in a 3-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1412B) for COVID-19 prophylaxis.     It was unknown if the patient ever been diagnosed with/ tested positive for COVID-19.          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.      No concomitant medication was provided.  Patient received Dose 1 in Deltoid muscle. Vaccines stored in the refrigerator that underwent several temperature excursions going back to August 2022. The vaccine had undergone several temperature excursions and might got administered to patients.  The patient received Dose 2, Dose 3 and Dose 4 of Moderna vaccine intramuscular in deltoid muscle.  The vaccines were stored in the Refrigerator. There were 2 unbroken cartons with 20 vials. Date vial was moved from freezer to refrigerator on 07-Sep-2022. Vials were not visualized for Visual inspection.  It was reported that refrigeration excursions identified, state vaccine was housed in these units. There were excursions noted.    It was reported that no adverse reactions were reported to their knowledge for the patient.  Treatment medication was not provided by the reporter.
Arm became swollen at injection site the night following vaccine. Pain and stiffness shoulder progressively got worse. Visited urgent care. 9-26-14 advised to take ibuprofen or TYLENOL. Pain and stiffness.
Pt developed a 4cm X 6cm erythema and edema at injection site.
Headache, Myalgia, NauseaVomiting, Chills, and Fatigue Narrative:
High fever 103 degrees rectal per parent within 8-10 hours following DTaP, HepB, IPV, Hib, PCV7 on 11/13/06. Fever resolved on 11/14/06
Patient stated that he was lightheaded. Patient presented with diaphoresis.  Denies C/P, SOB, difficulty breathing. BP 142/92, P73, 02 98%RA. Patient stayed for approximately 20 mins post reaction. Upon reassessment, patient was no longer diaphoretic, or feeling lightheaded and states symptoms are resolved and at this time. Patient is breathing easy, respiration are unlabored, and color pink. Patient is refusing any further medical treatment and transportation. Patient ambulatory to car.
One week after receiving my first dose of the Pfizer vaccine, I noticed heart palpitations as I was sitting in the car on a trip. These became more frequent in the days and weeks that followed. I tried to ignore them and hoped they would just go away, but in March, while driving my daughter, my heart felt very jumpy and would not calm down. I had an uncomfortable feeling in my chest. I had no idea what was happening so I made an appointment with doctor. He listened to my heartbeat, ran an EKG, and confirmed that I was having a lot of irregular beats and referred me to a cardiologist. I saw doctor on March 31 who also listened to my heartbeat, ran an EKG and attached a week long heart monitor  to my chest to see how often the extra beats were happening. At this time, I was not having extra beats all the time, only occasionally. After the monitor, my heart palpitations became more relentless. I had trouble sleeping at times, and I noticed my heart pounding all the time. Doctor then scheduled an ultrasound on June 1. The ultrasound showed that everything about my heart was healthy and normal except that the lower chamber was beating early. She referred me to doctor who explained what could be done to fix it. I do not want to have a procedure to fix this problem. I am still hopeful that it will go away on its own. I have had several weeks of normal heartbeats but then the palpitations come back again!
Patient refers an episode of metromenorrhagia immediately after receiving her second dose of Moderna Vaccine. The patient refers it happened before during her first dose of vaccine. Previous VAERS was filled, and this VAERS is to report continuation of symptoms. Recommendation was to visit her OB/GYN. Currently, episodes have subsided.
Information has been received from a nurse concerning a female who was vaccinated with her first dose of Gardasil. Subsequently the patient experienced fainting episode. At the time of the report the patient's outcome was unknown. Additional information has been requested.
4x4 cm indurated, erythematous lesion, warm to touch. No red streaking. Seen in urgent care center, treated with Motrin/cold compress